Cargando…
Cutaneous mucormycosis by Rhizopus arrhizus treated with isavuconazole as first line therapy: A case report
Mucormycosis are a group of infections that affect principally immunocompromised host and have a high mortality. Liposomal amphotericin B is the first-line treatment with combined surgical removal of the infectious focus. We report the case of 67-year-old man with idiopathic granulocytic aplasia and...
Autores principales: | Zuglian, G., Ripamonti, D., Tebaldi, A., Rizzi, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812037/ https://www.ncbi.nlm.nih.gov/pubmed/31667060 http://dx.doi.org/10.1016/j.mmcr.2019.10.002 |
Ejemplares similares
-
Successful treatment of Rhizopus arrhizus rhino-orbital-cerebral mucormycosis with isavuconazole salvage therapy following extensive debridement
por: Miller, R.P., et al.
Publicado: (2021) -
Successful Treatment of Mucormycosis Caused by Rhizopus arrhizus With Amphotericin B and Itraconazole
por: Cham, Chen Yi, et al.
Publicado: (2023) -
Ventriculitis due to infection with Rhizopus arrhizus
por: Hagel, Stefan, et al.
Publicado: (2015) -
Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2020) -
Case report of penile Rhizopus arrhizus infection in an unexpected patient
por: Bezzant, Matthew, et al.
Publicado: (2019)